Changing the treatment paradigm for vascular calcification.

Founded in 2005 in Palma de Mallorca, Sanifit is a biopharmaceutical company developing treatments for progressive calcification disorders.  Its product pipeline is focused on two indications in End Stage Kidney Disease patients: calciphylaxis and peripheral artery disease.

In 2021, Sanifit was acquired by Vifor Pharma.

Fund

Alta Life Sciences Spain I FCR

Sector

Therapeutics

Website

Exit year

2021